论文部分内容阅读
过去,胸腺瘤的性质难以判断。即使在组织学上证实是良性的,但实质上仍按恶性肿瘤对待。Bergh等把胸腺瘤像癌那样进行病期分类。在日本广泛应用正冈的Ⅰ～Ⅲ期的临床病期分类方法,即Ⅰ期完全包膜型,Ⅱ期被膜浸润型,Ⅲ期以上为浸润型胸腺瘤。病理组织学以上皮型发生率为高。自1980年将CT应用于临床诊断以来,术前病期诊断提高了。本文报道胸腺肿瘤计44例,其中胸腺瘤30例,胸腺癌4例,其他10例。按正冈的分类标准,胸腺瘤中Ⅰ期16例(53%),Ⅱ期5例(17%),Ⅲ期7例(23%),Ⅳ期2例(7%)。同CT的一致率略低,为80%,本文仅叙述胸腺瘤的外科疗法。Ⅰ、Ⅱ期首选外科治疗,施行完全切除术。吉竹
In the past, the nature of thymoma was difficult to judge. Even if it is confirmed to be benign on histology, it is still treated as a malignant tumor. Bergh et al. classified thymic tumors like cancer. In Japan, a wide range of clinical stages I-III classification methods are used in Zhenggang, ie, stage I fully encapsulated, stage II infiltrating, and stage III or more invasive thymoma. Histopathologically, the incidence of epithelial type was high. Since the application of CT in clinical diagnosis in 1980, the preoperative diagnosis has been improved. In this paper, we report 44 cases of thymic tumors, including 30 cases of thymoma, 4 cases of thymic carcinoma, and 10 cases of other. According to the classification criteria of Zheng Gang, 16 cases (53%) of stage I thymomas, 5 cases (17%) of stage II, 7 cases (23%) of stage III, and 2 cases (7%) of stage IV. The agreement rate with CT is slightly lower at 80%. This article only describes the surgical treatment of thymoma. Stage I and II surgical treatment is preferred and complete resection is performed. Yoshitake